|
1
|
Kuwahara A, Saito T and Kobayashi M: Bile
acids promote carcinogenesis in the remnant stomach of rats. J
Cancer Res Clin Oncol. 115:423–428. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ross RK, Hartnett NM, Bernstein L and
Henderson BE: Epidemiology of adenocarcinomas of the small
intestine: Is bile a small bowel carcinogen? Br J Cancer.
63:143–145. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reveille RM, Van Stiegmann G and Everson
GT: Increased secondary bile acids in a choledochal cyst. Possible
role in biliary metaplasia and carcinoma. Gastroenterology.
99:525–527. 1990.PubMed/NCBI
|
|
4
|
Bayerdörffer E, Mannes GA, Ochsenkühn T,
Dirschedl P, Wiebecke B and Paumgartner G: Unconjugated secondary
bile acids in the serum of patients with colorectal adenomas. Gut.
36:268–273. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martinez JD, Stratagoules ED, LaRue JM,
Powell AA, Gause PR, Craven MT, Payne CM, Powell MB, Gerner EW and
Earnest DL: Different bile acids exhibit distinct biological
effects: The tumor promoter deoxycholic acid induces apoptosis and
the chemopreventive agent ursodeoxycholic acid inhibits cell
proliferation. Nutr Cancer. 31:111–118. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morvay K, Szentléleki K, Török G, Pintér
A, Börzsönyi M and Nawroth R: Effect of change of fecal bile acid
excretion achieved by operative procedures on
1,2-dimethylhydrazine-induced colon cancer in rats. Dis Colon
Rectum. 32:860–863. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qiao D, Gaitonde SV, Qi W and Martinez JD:
Deoxycholic acid suppresses p53 by stimulating proteasome-mediated
p53 protein degradation. Carcinogenesis. 22:957–964. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Trauner M, Meier PJ and Boyer JL:
Molecular pathogenesis of cholestasis. N Engl J Med. 339:1217–1227.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sokol RJ, McKim JM Jr, Goff MC Jr, Ruyle
SZ, Devereaux MW, Han D, Packer L and Everson G: Vitamin E reduces
oxidant injury to mitochondria and the hepatotoxicity of
taurochenodeoxycholic acid in the rat. Gastroenterology.
114:164–174. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dueland S, Reichen J, Everson GT and Davis
RA: Regulation of cholesterol and bile acid homoeostasis in
bile-obstructed rats. Biochem J. 280:373–377. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Choi J and Ou JH: Mechanisms of liver
injury. III. Oxidative stress in the pathogenesis of hepatitis C
virus. Am J Physiol Gastrointest Liver Physiol. 290:G847–G851.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dröge W: Oxidative stress and aging. Adv
Exp Med Biol. 543:191–200. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang GWM and Kam PCA: The physiological
and pharmacological roles of cytochrome P450 isoenzymes.
Anaesthesia. 54:42–50. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Renton KW: Alteration of drug
biotransformation and elimination during infection and
inflammation. Pharmacol Ther. 92:147–163. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu AY: The 1996 Bernard B. Brodie lecture:
A journey in cytochrome P450 and drug metabolism research. Drug
Metab Dispos. 26:1168–1173. 1998.PubMed/NCBI
|
|
16
|
Conney AH: Induction of drug-metabolizing
enzymes: A path to the discovery of multiple cytochromes P450. Annu
Rev Pharmacol Toxicol. 43:1–30. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Coon MJ: Cytochrome P450: Nature's most
versatile biological catalyst. Annu Rev Pharmacol Toxicol. 45:1–25.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim D and Guengerich FP: Cytochrome P450
activation of arylamines and heterocyclic amines. Annu Rev
Pharmacol Toxicol. 45:27–49. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma Q and Lu AY: CYP1A induction and human
risk assessment: An evolving tale of in vitro and in vivo studies.
Drug Metab Dispos. 35:1009–1016. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Proctor RN: Tobacco and the global lung
cancer epidemic. Nat Rev Cancer. 1:82–86. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Whitlock JP Jr, Chichester CH, Bedgood RM,
Okino ST, Ko HP, Ma Q, Dong L, Li H and Clarke-Katzenberg R:
Induction of drug-metabolizing enzymes by dioxin. Drug Metab Rev.
4:1107–1127. 1997. View Article : Google Scholar
|
|
22
|
Gillner M, Bergman J, Cambillau C and
Gustafsson JA: Interactions of rutaecarpine alkaloids with specific
binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver.
Carcinogenesis. 10:651–654. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gillner M, Bergman J, Cambillau C and
Alexandersson M: Fernström B and Gustafsson JA: Interactions of
indolo[3,2-b]carbazoles and related polycyclic aromatic
hydrocarbons with specific binding sites for
2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol Pharmacol.
44:336–345. 1993.PubMed/NCBI
|
|
24
|
Ciolino HP, Daschner PJ, Wang TT and Yeh
GC: Effect of curcumin on the aryl hydrocarbon receptor and
cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem
Pharmacol. 56:197–206. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gradelet S, Leclerc J, Siess MH and Astorg
PO: β-Apo-8-carotenal, but not β-carotene, is a strong inducer of
liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica. 26:909–919.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Perdew GH and Babbs CF: Production of Ah
receptor ligands in rat fecal suspensions containing tryptophan or
indole-3-carbinol. Nutr Cancer. 16:209–218. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ciolino HP, Daschner PJ and Yeh GC:
Dietary flavonols quercetin and kaempferol are ligands of the aryl
hydrocarbon receptor that affect CYP1A1 transcription
differentially. Biochem J. 340:715–722. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Canivenc-Lavier MC, Vernevaut MF, Totis M,
Siess MH, Magdalou J and Suschetet M: Comparative effects of
flavonoids and model inducers on drug-metabolizing enzymes in rat
liver. Toxicology. 114:19–27. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Whitlock JP Jr: Induction of cytochrome
P4501A1. Annu Rev Pharmacol Toxicol. 39:103–125. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kapitulnik J and Gonzalez FJ: Marked
endogenous activation of the CYP1A1 and CYP1A2 genes in the
congenitally jaundiced Gunn rat. Mol Pharmacol. 43:722–725.
1993.PubMed/NCBI
|
|
31
|
Parkin DM: Global cancer statistics in the
year 2000. Lancet Oncol. 2:533–543. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zollner G, Marschall HU, Wagner M and
Trauner M: Role of nuclear receptors in the adaptive response to
bile acids and cholestasis: Pathogenetic and therapeutic
considerations. Mol Pharm. 3:231–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Barone M, Maiorano E, Ladisa R, Cuomo R,
Pece A, Berloco P, Caruso ML, Valentini AM, Iolascon A, Francavilla
A, et al: Influence of ursodeoxycholate-enriched diet on liver
tumor growth in HBV transgenic mice. Hepatology. 37:880–886. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang CL, Zeng T, Zhao XL and Xie KQ:
Garlic oil attenuated nitrosodiethylamine-induced
hepatocarcinogenesis by modulating the metabolic activation and
detoxification enzymes. Int J Biol Sci. 9:237–245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ohno M, Ikenaka Y and Ishizuka M: Sudan
III dye strongly induces CYP1A1 mRNA expression in HepG2 cells. J
Biochem Mol Toxicol. 26:16–22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Amara IE, Anwar-Mohamed A and El-Kadi AO:
Mercury modulates the CYP1A1 at transcriptional and
posttranslational levels in human hepatoma HepG2 cells. Toxicol
Lett. 199:225–233. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qin P: Tang X, Elloso MM and Harnish DC:
Bile acids induce adhesion molecule expression in endothelial cells
through activation of reactive oxygen species, NF-kappaB, and p38.
Am J Physiol Heart Circ Physiol. 291:741–747. 2006. View Article : Google Scholar
|
|
38
|
Shibazaki M, Takeuchi T, Ahmed S and
Kikuchi H: Suppression by p38 MAP kinase inhibitors (pyridinyl
imidazole compounds) of Ah receptor target gene activation by
2,3,7,8-tetrachlorodibenzo-p-dioxin and the possible mechanism. J
Biol Chem. 279:3869–3876. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Korashy HM, Anwar-Mohamed A, Soshilov AA,
Denison MS and El-Kadi AO: The p38 MAPK inhibitor SB203580 induces
cytochrome P450 1A1 gene expression in murine and human hepatoma
cell lines through ligand-dependent aryl hydrocarbon receptor
activation. Chem Res Toxicol. 24:1540–1548. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Allen K, Kim ND, Moon JO and Copple BL:
Upregulation of early growth response factor-1 by bile acids
requires mitogen-activated protein kinase signaling. Toxicol Appl
Pharmacol. 243:63–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Reiners JJ Jr, Lee JY, Clift RE, Dudley DT
and Myrand SP: PD98059 is an equipotent antagonist of the aryl
hydrocarbon receptor and inhibitor of mitogen-activated protein
kinase kinase. Mol Pharmacol. 53:438–445. 1998.PubMed/NCBI
|
|
42
|
Perdew GH: Association of the Ah receptor
with the 90-kDa heat shock protein. J Biol Chem. 263:13802–13805.
1988.PubMed/NCBI
|
|
43
|
Meyer BK and Perdew GH: Characterization
of the AhR-hsp90-XAP2 core complex and the role of the
immunophilin-related protein XAP2 in AhR stabilization.
Biochemistry. 38:8907–8917. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Heid SE, Pollenz RS and Swanson HI: Role
of heat shock protein 90 dissociation in mediating agonist-induced
activation of the aryl hydrocarbon receptor. Mol Pharmacol.
57:82–92. 2000.PubMed/NCBI
|
|
45
|
Refat NA, Ibrahim ZS, Moustafa GG,
Sakamoto KQ, Ishizuka M and Fujita S: The induction of cytochrome
P450 1A1 by sudan dyes. J Biochem Mol Toxicol. 22:77–84. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lubet RA, Connolly G, Kouri RE, Nebert DW
and Bigelow SW: Biological effects of the Sudan dyes. Role of the
Ah cytosolic receptor. Biochem Pharmacol. 32:3053–3058. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dewa Y, Nishimura J, Muguruma M, Jin M,
Kawai M, Saegusa Y, Okamura T, Umemura T and Mitsumori K:
Involvement of oxidative stress in hepatocellular tumor-promoting
activity of oxfendazole in rats. Arch Toxicol. 83:503–511. 2009.
View Article : Google Scholar : PubMed/NCBI
|
